Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Net Assets
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has net assets worth CN¥1.88 Billion CNY (≈ $274.76 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.58 Billion ≈ $377.22 Million USD) and total liabilities (CN¥700.20 Million ≈ $102.46 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shandong Bailong Chuangyuan Bio-Tech Co. (605016) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.88 Billion |
| % of Total Assets | 72.84% |
| Annual Growth Rate | 21.12% |
| 5-Year Change | 142.98% |
| 10-Year Change | N/A |
| Growth Volatility | 19.79 |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Net Assets Trend (2016–2024)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore 605016 asset base for the complete picture of this company's asset base.
Annual Net Assets for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2024)
The table below shows the annual net assets of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2024. For live valuation and market cap data, see Shandong Bailong Chuangyuan Bio-Tech Co. market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.68 Billion ≈ $245.73 Million |
+11.37% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.64 Million |
+12.11% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
+11.76% |
| 2021-12-31 | CN¥1.20 Billion ≈ $176.10 Million |
+74.14% |
| 2020-12-31 | CN¥691.09 Million ≈ $101.13 Million |
+15.75% |
| 2019-12-31 | CN¥597.07 Million ≈ $87.37 Million |
+19.01% |
| 2018-12-31 | CN¥501.71 Million ≈ $73.42 Million |
+14.96% |
| 2017-12-31 | CN¥436.41 Million ≈ $63.86 Million |
+20.33% |
| 2016-12-31 | CN¥362.67 Million ≈ $53.07 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4348.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥801.88 Million | 47.75% |
| Common Stock | CN¥323.09 Million | 19.24% |
| Other Comprehensive Income | CN¥120.03 Million | 7.15% |
| Other Components | CN¥434.23 Million | 25.86% |
| Total Equity | CN¥1.68 Billion | 100.00% |
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Market Cap
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TECNOGLASS INC. DL-0001
F:7FH
|
$1.70 Billion |
|
Winpak Ltd.
TO:WPK
|
$1.70 Billion |
|
Chengdu ALD Aviation Manufacturing Corp
SHE:300696
|
$1.70 Billion |
|
Kyland Technology Co Ltd
SHE:300353
|
$1.70 Billion |
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd A
SHG:600648
|
$1.69 Billion |
|
Louis HachEtte Group SA
PA:ALHG
|
$1.69 Billion |
|
Sixth Street Specialty Lending Inc
NYSE:TSLX
|
$1.69 Billion |
|
PT Super Bank Indonesia Tbk
JK:SUPA
|
$1.69 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,507,827,547 to 1,679,237,143, a change of 171,409,596 (11.4%).
- Net income of 245,598,463 contributed positively to equity growth.
- Dividend payments of 77,988,370 reduced retained earnings.
- Other comprehensive income increased equity by 26,336,998.
- Other factors decreased equity by 22,537,495.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥245.60 Million | +14.63% |
| Dividends Paid | CN¥77.99 Million | -4.64% |
| Other Comprehensive Income | CN¥26.34 Million | +1.57% |
| Other Changes | CN¥-22.54 Million | -1.34% |
| Total Change | CN¥- | 11.37% |
Book Value vs Market Value Analysis
This analysis compares Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.31x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 12.07x to 5.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | CN¥2.28 | CN¥27.58 | x |
| 2017-12-31 | CN¥2.34 | CN¥27.58 | x |
| 2018-12-31 | CN¥2.69 | CN¥27.58 | x |
| 2019-12-31 | CN¥3.28 | CN¥27.58 | x |
| 2020-12-31 | CN¥3.88 | CN¥27.58 | x |
| 2021-12-31 | CN¥6.75 | CN¥27.58 | x |
| 2022-12-31 | CN¥5.41 | CN¥27.58 | x |
| 2023-12-31 | CN¥4.69 | CN¥27.58 | x |
| 2024-12-31 | CN¥5.20 | CN¥27.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.63%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 21.33%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.20x
- Recent ROE (14.63%) is above the historical average (13.39%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 17.87% | 19.31% | 0.53x | 1.74x | CN¥28.53 Million |
| 2017 | 14.60% | 20.52% | 0.50x | 1.43x | CN¥20.09 Million |
| 2018 | 13.02% | 18.37% | 0.58x | 1.22x | CN¥15.13 Million |
| 2019 | 13.86% | 19.66% | 0.56x | 1.26x | CN¥23.08 Million |
| 2020 | 13.83% | 19.12% | 0.60x | 1.21x | CN¥26.44 Million |
| 2021 | 8.68% | 15.99% | 0.51x | 1.07x | CN¥-15.87 Million |
| 2022 | 11.21% | 20.88% | 0.49x | 1.09x | CN¥16.26 Million |
| 2023 | 12.80% | 22.23% | 0.49x | 1.16x | CN¥42.21 Million |
| 2024 | 14.63% | 21.33% | 0.57x | 1.20x | CN¥77.67 Million |
Industry Comparison
This section compares Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,994,389,347
- Average return on equity (ROE) among peers: 11.88%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) | CN¥1.88 Billion | 17.87% | 0.37x | $1.70 Billion |
| Shenzhen Shenbao Industrial Co Ltd (000019) | $296.80 Million | 11.46% | 0.53x | $1.26 Billion |
| Hainan Pearl River Holdings Co Ltd (000505) | $585.78 Million | -31.84% | 1.22x | $648.05 Million |
| Xiwang Foodstuffs Co Ltd (000639) | $76.25 Million | 11.36% | 0.86x | $304.85 Million |
| Nanfang Black Sesame Group Co Ltd (000716) | $2.71 Billion | 2.87% | 0.70x | $570.04 Million |
| CNFC Overseas Fishery Co Ltd (000798) | $256.68 Million | 54.64% | 0.92x | $499.50 Million |
| Henan Shuanghui Investment & Development Co Ltd (000895) | $23.15 Billion | 21.02% | 0.47x | $14.05 Billion |
| Xinjiang Chalkis Co Ltd (000972) | $628.09 Million | 8.48% | 2.86x | $440.17 Million |
| Zhengzhou Qianweiyangchu Food Co Ltd (001215) | $1.82 Billion | 4.59% | 0.27x | $687.56 Million |
| Qingdao Foods Co Ltd (001219) | $299.34 Million | 12.12% | 0.20x | $447.10 Million |
| Shandong Oriental Ocean Sci-Tech Co Ltd (002086) | $117.09 Million | 24.08% | 1.95x | $584.78 Million |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more